Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksAKUMS
resources
AKUMS

Akums Drugs & Pharmaceuticals Ltd.

NSE: AKUMS
BSE: 544222
Sector: Healthcare
Industry: Pharmaceuticals
647.35-3.3 (-0.50%)
8 Jul, 12:00 AM

Annual Reports and Financial Documents

Akums Drugs & Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
202420252026
Annual Reports—FY 2025FY 2026
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Akums Drugs & Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20188 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate pursuant to Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018
  • General4 Jul 2026
    Update On Penalty Imposed By The Deputy Commissioner Of State Tax, Gujarat, On Maxcure Nutravedics Limited, Wholly Owned Subsidiary Of The Company
    Update on penalty imposed by the Deputy Commissioner of State Tax, Gujarat, on Maxcure Nutravedics Limited, wholly owned subsidiary of the Company
  • Closure of Trading Window25 Jun 2026
    Closure of Trading Window
    Closure of Trading Window
  • Newspaper Publication19 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Advertisements of the 22nd Annual General Meeting of the Company
  • General19 Jun 2026
    Notice And Integrated Annual Report For The Financial Year 2025-26 To Those Members Who Have Not Registered Their E-Mail ID'S
    Notice and Integrated Annual Report for the Financial Year 2025-26 to those members who have not registered their e-mail ID''s
  • Business Responsibility and Sustainability Reporting (BRSR)18 Jun 2026
    Business Responsibility and Sustainability Reporting (BRSR)
    Business Responsibility and Sustainability Reporting for the FY 2025-26
  • Reg. 34 (1) Annual Report18 Jun 2026
    Reg. 34 (1) Annual Report.
    Integrated Annual Report for the FY 2025-26
  • General18 Jun 2026
    Notice Of The 22Nd Annual General Meeting
    Notice of the 22nd Annual General Meeting
  • Newspaper Publication16 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Advertisement- Information regarding 22nd AGM and Final & Special Dividend
  • Analyst / Investor Meet10 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Schedule of the investor/analysts meets
  • Analyst / Investor Meet9 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Schedule of the Investor/Analyst Meet
  • Analyst / Investor Meet3 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Schedule of the Investor/Analysts Meet
  • Analyst / Investor Meet28 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Schedule of the Investor/Analysts Conference Call (group meet)
  • General22 May 2026
    Receipt Of Assessment Order(S) By Certain Subsidiaries From Income Tax Department
    Receipt of Assessment Order(s) by certain subsidiaries from Income Tax Department
  • General20 May 2026
    Receipt Of Assessment Order(S) From Income Tax Department
    Receipt of Assessment Order(s) from Income Tax Department
  • Analyst / Investor Meet18 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Link of Audio Recording of Investor/Analyst Conference Call
  • General18 May 2026
    Update On Disruption In Operations At Some Of The Manufacturing Sites At Haridwar
    Update on Disruption in Operations at come of the Manufacturing Sites at Haridwar
  • Reg.24(A)-Annual Secretarial Compliance16 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Secretarial Compliance Report for the FY 2025-26
  • General16 May 2026
    Update On Disruption In Operations At Some Of The Manufacturing Sites At Haridwar
    Update on Disruption in Operations at some of the manufacturing sites at Haridwar
  • Newspaper Publication15 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Intimation regarding Newspaper Publication

Frequently Asked Questions

Where can I download the annual report of Akums Drugs & Pharmaceuticals Ltd.?
Annual reports of Akums Drugs & Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Akums Drugs & Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Akums Drugs & Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Akums Drugs & Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Akums Drugs & Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Akums Drugs & Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Akums Drugs & Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Akums Drugs & Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Akums Drugs & Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Akums Drugs & Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Akums Drugs & Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Akums Drugs & Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Akums Drugs & Pharmaceuticals Ltd. is INE09XN01023. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Akums Drugs & Pharmaceuticals Ltd. listed?
Akums Drugs & Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is AKUMS and the BSE code is -.
Where can I find the shareholding pattern of Akums Drugs & Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Akums Drugs & Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Akums Drugs & Pharmaceuticals Ltd. on Sharpely?
Share price data for Akums Drugs & Pharmaceuticals Ltd. is updated as of 8 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.